MERCK & CO INC. COM (MRK) : Concannon Wealth Management scooped up 1,762 additional shares in MERCK & CO INC. COM during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Apr 21, 2016. The investment management firm now holds a total of 96,064 shares of MERCK & CO INC. COM which is valued at $5,450,671.MERCK & CO INC. COM makes up approximately 5.53% of Concannon Wealth Management’s portfolio.
MERCK & CO INC. COM opened for trading at $56.06 and hit $56.62 on the upside on Wednesday, eventually ending the session at $56.31, with a gain of 0.48% or 0.27 points. The heightened volatility saw the trading volume jump to 69,41,426 shares. Company has a market cap of $156,275 M.
Other Hedge Funds, Including , Meritage Portfolio Management added MRK to its portfolio by purchasing 87,614 company shares during the most recent quarter which is valued at $4,971,218. MERCK & CO INC. COM makes up approx 0.56% of Meritage Portfolio Management’s portfolio.Umb Bank N Amo boosted its stake in MRK in the latest quarter, The investment management firm added 903 additional shares and now holds a total of 306,974 shares of MERCK & CO INC. COM which is valued at $17,417,705. MERCK & CO INC. COM makes up approx 0.73% of Umb Bank N Amo’s portfolio.Bath Savings Trust Co boosted its stake in MRK in the latest quarter, The investment management firm added 162 additional shares and now holds a total of 7,109 shares of MERCK & CO INC. COM which is valued at $399,099. MERCK & CO INC. COM makes up approx 0.13% of Bath Savings Trust Co’s portfolio.Daiwa Sb Investments Ltd. reduced its stake in MRK by selling 4,815 shares or 2.76% in the most recent quarter. The Hedge Fund company now holds 169,610 shares of MRK which is valued at $9,521,905. MERCK & CO INC. COM makes up approx 2.39% of Daiwa Sb Investments Ltd.’s portfolio.Fruth Investment Management reduced its stake in MRK by selling 100 shares or 0.89% in the most recent quarter. The Hedge Fund company now holds 11,162 shares of MRK which is valued at $614,468. MERCK & CO INC. COM makes up approx 0.31% of Fruth Investment Management’s portfolio.
On the company’s financial health, MERCK & CO INC. COM reported $0.93 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Feb 3, 2016. Analyst had a consensus of $0.91. The company had revenue of $10215.00 million for the quarter, compared to analysts expectations of $10355.20 million. The company’s revenue was down -2.5 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.87 EPS.
Many Wall Street Analysts have commented on MERCK & CO INC. COM. Societe Generale Initiated MERCK & CO INC. COM on Apr 6, 2016 to “Buy”, Price Target of the shares are set at $80.MERCK & CO INC. COM was Downgraded by BofA/Merrill to ” Neutral” on Jan 27, 2016.
Merck & Co. Inc. is a global health care company. The Company offers health solutions through its prescription medicines vaccines biologic therapies and animal health products which it markets directly and through its joint ventures. The Companys Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents generally sold by prescription for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers hospitals government agencies and managed health care providers. The Animal Health segment discovers develops manufactures and markets animal health products including vaccines. The Companys animal health products are sold to veterinarians distributors and animal producers.